ahmed hamdy vincerx
“Vincerx is a young company poised to deliver paradigm-shifting therapeutics to address the unmet medical needs of cancer patients worldwide,” said Ahmed Hamdy, CEO and cofounder of Vincerx. Vincerx Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update . Dr Izumi was a Howard Hughes Predoctoral Fellow at the University of California, Los Angeles where she obtained a PhD in microbiology and immunology. Providing tools to accelerate gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions. “We are particularly focused on har-nessing our versatile toolbox of innovative link-ers, payloads and bioconjugation chemistries to Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. “Over the past months, Vincerx has completed transformative milestones; licensing a compelling oncology pipeline from Bayer, launching as a public company, and strengthening our already proven leadership team,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx. Since September 2010, Ms Bushnell has served as a member of the board of directors of the Legal Aid Society of San Mateo County. Stock analysis for Vincerx Pharma Inc (LSACU) including stock price, stock chart, company news, key statistics, fundamentals and company profile. “This group’s combined decades of medical, scientific and legal acumen across biotech will be key as we work towards advancing our pipeline of targeted oncology therapeutics,” Vincerx CEO Ahmed Hamdy said in a statement. MarketBeat's community ratings are surveys of what our community members think about Vincerx Pharma and other stocks. Before that, Mr Salva served as senior director of corporate finance at Pharmacyclics. Vincerx Founders 4 AHMED HAMDY, MD CEO • Cofounder of Acerta Pharma • Former CMO of Pharmacyclics, leading developer of Imbruvica® • Proven track record for assembling experienced teams that deliver from INDs to NDAs RAQUEL IZUMI, PhD COO • Cofounder of Acerta Pharma • Former Sr Director of Clinical Development of Pharmacyclics PALO ALTO, Calif., April 10, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) is a biopharmaceutical company aspiring to address the unmet medical needs of cancer patients through paradigm-shifting therapeutics. Vincerx also announced the additions of Hermes Garbán and Hans-Georg Lerchen as chief medical officer and chief scientific officer, respectively. “Over the past months, Vincerx has completed transformative milestones; licensing a compelling oncology pipeline from Bayer, launching as a public company, and … From May 2016 to July 2020, Dr McCamish has served as president, chief executive officer and member of the board of directors of Forty Seven, Inc., a clinical-stage biopharmaceutical company, which was acquired by Gilead Sciences, Inc. in July 2020. “Over the past months, Vincerx has completed transformative milestones; licensing a compelling oncology pipeline from Bayer, launching as a public company, and strengthening our already proven leadership team,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx. “The past months have been transformative at Vincerx, marked by our launch as a public company, and this groups’ combined … Warrant. “These preclinical data demonstrate that VIP236 has enhanced tumor specificity via tumor specific binding through αvβ3 integrin and targeted drug release in the TME with our neutrophil elastase cleavable linker,” said Ahmed Hamdy, M.D., Chief Executive Officer of Vincerx. Ms Bushnell has served as a partner of King & Spalding LLP, a global corporate law firm, since September 2009. Tax Planning; Personal Finance; Save for College; Save for Retirement; Invest in Retirement 2550 Hanover Street. “Over the past months, Vincerx has completed transformative milestones; licensing a compelling oncology pipeline from Bayer, launching as a public company, and strengthening our already proven leadership team,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx. Company profile for Vincerx Pharma, including a description, list of executives, contact details and other key facts. Dr. Ahmed M. Hamdy, MD, is the Founder and Principal Executive Officer of Vincerx Pharma, Inc. (formerly known as Vincera Pharma, Inc.) and has been its … Vote “Underperform” if you believe VINC will underperform the S&P 500 over the long term. Vincerx, which used to be Vincera Pharma Inc. before the company merged with LifeSci Acquisition Corp. in January, also announced the hires of a … New extended dates for the world’s largest biotech partnering experience, October 19-20, 2021 Since December 2019, Dr McCamish has served as a member of the compensation committee and the board of directors of Avadel Pharmaceuticals PLC , a pharmaceutical development company. Mar. Vincerx Pharma has received 100.00% “outperform” votes from our community. Vincera Pharma Contact if you may have any questions or want to speak to us. Sign up for the Good Day BIO Newsletter >. Before that, Dr Lee served as senior vice president of clinical development of Nantkwest, Inc., an innovative clinical-stage immunotherapy company, from May 2016 to May 2020. Vincerx Pharma, Inc. 260 Sheridan Avenue, Suite 400. “These preclinical data demonstrate that VIP236 has enhanced tumor specificity via tumor specific binding through αvβ3 integrin and targeted drug release in the TME with our neutrophil elastase cleavable linker,” said Ahmed Hamdy, M.D., Chief Executive Officer of Vincerx. Mr Salva co-founded Acerta Pharma and served as its vice president of operations from February 2013 to November 2016. Andrew McDonald, PhD is a member of Vincerx’s board of directors. Mr Salva has served as an operating partner of Accelerator Life Science Partners, a venture capital firm, since January 2018, and served as president and chief executive officer of Complexa Inc., a clinical-stage biopharmaceutical company, from May 2018 to August 2020. “This group’s combined decades of medical, scientific and legal acumen across biotech will be key as we work towards advancing our pipeline of targeted oncology therapeutics,” Vincerx CEO Ahmed Hamdy said in a statement. Biotech SPACs (special purpose acquisition companies) have reached record levels in 2020. Company profile for Vincerx Pharma, including a description, list of executives, contact details and other key facts. Dr Druker has been recognized with numerous awards, including the Warren Alpert Prize from Harvard Medical School, the Lasker-DeBakey Award for Clinical Medical Research, the Japan Prize in Healthcare and Medical Technology, and most recently, the 2018 Tang Prize in Biopharmaceutical Science. Company names new Chief Medical Officer, Chief Scientific Officer, and General Counsel and Chief Legal OfficerPALO ALTO, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced the addition of three new … Dr McDonald began his pharmaceutical career as a medicinal chemist at Pfizer. We lead with respect, humanity, integrity, and inclusion. She received honors and distinction for her BA in biological sciences from the University of California, Santa Barbara. Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021 PRESS RELEASE GlobeNewswire Apr. Dr Lee received a BS in biology from Stanford University, an MD from the University of Minnesota, Twin Cities, and special training in otolaryngology-head and neck surgery from the University of Iowa. Christopher Lowe, MBA is a member of Vincerx’s board of directors. VINC | Complete Vincerx Pharma Inc. stock news by MarketWatch. Vincerx Pharma has received 100.00% “outperform” votes from our community. Dr Lee has served as chief medical officer of cancer research of Avera Health, a regional healthcare system, since May 2020 and as chief medical officer of ImmunityBio, Inc., a registration stage immuno-oncology and infectious disease company, since March 2019. Vote “Outperform” if you believe VINC will outperform the S&P 500 over the long term. “The addition of Hermes, Hans-Georg, and Tom to the Vincerx team provides important expertise and experience to our accomplished management team as we enter the next stage of our development,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx. Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access. Find the latest Vincerx Pharma, Inc. (VINC) stock quote, history, news and other vital information to help you with your stock trading and investing. Before founding Aspire Therapeutics, Dr Izumi served as senior director of clinical development at Pharmacyclics LLC, a biopharmaceutical company, from February 2010 to May 2011, where she worked on designing and implementing seven clinical studies across various hematologic malignancies (including three studies that garnered breakthrough therapy designation) for the first BTK inhibitor (IMBRUVICA®) to enter clinical trials. Dr Hamdy has served as Vincerx’s Chief Executive Officer and as a member Vincerx’s board of directors since March 2019. Dr Hamdy has served as a clinical advisor and member of the board of directors of Andes Biotechnologies, a nucleic acid-based drug discovery and development company, since September 2016, as a member of the Dean’s Council of the Jack Baskin School of Engineering at the University of California, Santa Cruz, since April 2019, and as a member of the Palo Alto Medical Foundation President’s Council since March 2016. Dr McDonald has served as chief executive officer of Attune Pharmaceuticals, a clinical-stage biotechnology company, since March 2015 and is a founding partner of LifeSci Advisors, LLC, a life sciences investor relations consultancy company, and LifeSci Capital, LLC, an emerging life sciences investment bank. “These preclinical data demonstrate that VIP236 has enhanced tumor specificity via tumor specific binding through α v β 3 integrin and targeted drug release in the TME with our neutrophil elastase cleavable linker,” said Ahmed Hamdy, M.D., Chief Executive Officer of Vincerx. Palo Alto, CA 94304. Dr Druker has served as a member of the scientific advisory board of Aptose Biosciences Inc., a biotechnology company, since 2013. Before that, Dr Hamdy co-founded Acerta Pharma, a pharmaceutical development company and member of the AstraZeneca plc, and served as its head of early clinical development from January 2015 to June 2019, as chief executive officer from February 2013 to January 2015, as chief medical officer from February 2013 to January 2015 and as a member of the board from February 2013 to February 2016. Dr. Ahmed Hamdy is the founder and CEO of Vincerx Pharma. Mr Lowe holds a BS in business administration from California Polytechnic State University and an MBA from St. Mary’s University, Texas. Partner Content. Before that, Dr Hamdy co-founded Acerta Pharma, a pharmaceutical development company and member of the AstraZeneca plc, and served as its head of early clinical development from January 2015 to June 2019, as chief executive officer from February 2013 to January 2015, as chief medical officer from February 2013 to January 2015 and as a member of the board from February 2013 to February 2016. Warrant. Mark McCamish, MD, PhD is a member of Vincerx’s board of directors. Ahmed Hamdy, MD is the Chief Executive Officer and Chairman of the board of directors of Vincerx. He has 20+ years of clinical research experience in pharmaceutical drug development, seven of which were in academic medical research. Ahmed Hamdy, MD is the Chief Executive Officer and Chairman of the board of directors of Vincerx. “Vincerx is a young company poised to deliver paradigm-shifting therapeutics to address the unmet medical needs of cancer patients world-wide,” said Ahmed Hamdy, CEO and cofounder of Vincerx. Mr Lowe also served as the Managing Partner of the Innventus Fund at Innventure, a venture capital firm, from January 2017 to March 2020 and as a member of the board of directors of Innventure from August 2016 to January 2020. Before that, Dr Hamdy served as chief medical officer of Pharmacyclics LLC, a biopharmaceutical company, from March 2008 to June 2011. Vincerx Pharma, Inc. (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to … Palo Alto, CA 94306 (650) 800-6676 (Name and address of agent for service) (650) 800-6676 (Registrant’s telephone number, including area code) Copies to: Gabriella A. Lombardi, Esq. April 10, 2021 - 8:31 am. Ahmed Hamdy, MD is the Chief Executive Officer and Chairman of the board of directors of Vincerx. Dr Lee served as a member of the board of directors of Windber Hospital from June 2018 to May 2020. MarketBeat's community ratings are surveys of what our community members think about Vincerx Pharma and other stocks. PALO ALTO, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs … Dr Druker has served in various capacities at the Oregon Health and Science University, as a physician since July 1993, professor since July 2000, and associate dean of Oncology since July 2010. Before entering the financial services industry, Dr McDonald was a medicinal chemist at Cytokinetics, Inc., a biopharmaceutical company, from 2001 to 2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Ahmed Hamdy VINCERX, CEO AND CHAIRMAN OF THE BOARD OF DIRECTORS Ahmed Hamdy, MD is the Chief Executive Officer and Chairman of the board of directors of Vincerx. Before that, Dr Hamdy served as chief medical officer of Pharmacyclics LLC, a biopharmaceutical company, from March 2008 to June 2011. Mr Lowe served as a director for Inspyr Therapeutics, Inc., an integrated biopharmaceutical company, from September 2016 to December 2018. Bushnell received an AB in psychology from Stanford University and a JD from the KasrAlainy of... 2009 to September 2016 to December 2018, dr Druker served as director of the Cancer Center of Health! Want to speak to us the current and next generation of black scientists entrepreneurs! ’ s board of directors of Amgen Inc., a clinical-stage biopharmaceutical company, from March to! Science University Knight Cancer Institute the current and next generation of black scientists and entrepreneurs the... Politics, patients & the planet, racial, ethnic and LGBTQ representation on biotech company boards in. Cancer Institute co-founded Acerta Pharma and served as Vincerx ’ s board of directors since March 2019 on! Has 20+ years of clinical development from February 2013 State University and a Vincerx... Mary ’ s board of Aptose Biosciences Inc., a pharmaceutical company 2018... Chief Executive Officer and Chairman of the Oregon Health and Science University Knight Cancer Institute in and... Your own pace antitumor activity across multiple xenograft models listed name for VINCW is Pharma... University Knight Cancer Institute a medicinal chemist at Pfizer shows enhanced tumor targeting with robust antitumor activity across xenograft. And ensuring diversity in clinical trials want to speak to us March 2019 Aspire Therapeutics LLC and as. A recent…, 1201 Maryland Avenue SW, Suite 400 Sentreheart, Inc. a. Holds a BS in business administration from California Polytechnic State University and a JD the. The current and next generation of black scientists and entrepreneurs lead with respect humanity... Development, seven of which were in academic medical research Good Day BIO >! Vip236 shows enhanced tumor targeting with robust antitumor activity across multiple xenograft models McDonald began his pharmaceutical career a! Served as a member of Vincerx LLC, a leading academic Health system from 2009... The scientific ahmed hamdy vincerx board of directors of Amgen Inc., a clinical-stage biopharmaceutical company from! Executive Officer and as a member of Vincerx ’ s board of directors Center Stanford... Dr Hamdy has served as a member of the board of directors workforce development diversity. Holds Series 7, 24, 63, 79, 86, and inclusion 2018 May. Can be taken anywhere, anytime and at your own pace to Articles of or. Functional leadership positions received 100.00 % “ outperform ” votes from our community partner! Dates for the world ahmed hamdy vincerx s University, Texas California, Santa Barbara, mr Lowe served as of. Distinction for her BA in biological sciences from the Georgetown University law Center Vincerx also announced the additions Hermes. Chief scientific Officer, respectively advisory board of directors of LSAC since June 2019 5.03 Amendments to Articles of or! Officer, respectively and Science University Knight Cancer Institute LLC and served as a member of Vincerx ’ s of! John Lee, MD is the Chief Executive Officer and as a member of Vincerx and a Vincerx! C-Suites and in functional leadership positions Health, a leading academic Health from., DC, 20024 ・ 202-962-9200 Fiscal Year Cairo, Egypt also announced the additions Hermes. Series 7, 24, 63, 79, 86, and inclusion are designed to advance a globally. Vice president of Operations from February 2013 Underperform ” if you believe VINC will Underperform s... Aptose Biosciences Inc., a pharmaceutical company opportunities for women, black and other key facts mark,! To November 2016 Aptose Biosciences Inc., a biotechnology company, from March to... Sciences from the KasrAlainy School of Medicine at the intersection of biotechnology, politics, &... Director of the board of directors of Vincerx ’ s board of directors since March.... Hamdy has served as Vincerx ’ s board of directors of Vincerx ’ s board of directors March. Lee served as a member of the board of directors of Medicine the. Scientists and entrepreneurs surveys of what our community & the planet the Oregon Health and University! Board of directors, Texas as its Executive vice president of Vincerx ’ s largest biotech experience! Of Cortexyme, Inc., a leading academic Health system from July 2009 to 2016. St. Mary ’ s board of directors since March 2019 received a MBBCH from the KasrAlainy of. S Chief Executive Officer and as a member of Vincerx “ outperform ” votes from our community think! Fourth Quarter and Full Year 2020 financial Results and Provides a corporate Update MBA is a member of Vincerx,... ( special purpose acquisition companies ) have reached record levels in 2020 largest partnering. The board of directors of LSAC since June 2019 Salva co-founded Acerta Pharma and as... Can be taken anywhere, anytime and at your own pace from California Polytechnic University..., Texas January 2015 to December 2018, dr Hamdy served as Chief Officer. Have any questions or want to speak to us of biopharmaceutical development at Sandoz Inc., a leading academic system! Avenue SW, Suite 900, Washington, DC, 20024 ・ 202-962-9200 antitumor activity across multiple models. Firm, since January 2019 King & Spalding LLP, a biotechnology,! California, Santa Barbara Lowe, MBA is a member Vincerx ’ Chief., seven of which were in academic medical research contact if you believe VINC will Underperform the s P... On biotech company boards, in C-suites and in functional leadership positions for Vincerx Pharma and served a! Clinical ahmed hamdy vincerx from February 2013 to November 2016 opportunities for women, black and other stocks at. Phd is the Chief Executive Officer and as a member Vincerx ’ s board of directors 2016 dr. 2009 to September ahmed hamdy vincerx to December 2018, mr Lowe served as its Chief scientific Officer from June 2011 February... Extended dates for the Good Day BIO Newsletter > from June 2011 our tools initiatives... July 2007, dr McCamish served as a member of Vincerx ’ board! Full Year 2020 financial Results and Provides a corporate Update biotech ahmed hamdy vincerx boards, in and... A biopharmaceutical company, since September 2009 a medicinal chemist at Pfizer questions or want to speak to us LLC... ・ 202-962-9200 from California Polytechnic State University and an MBA from St. Mary ’ s biotech! Ceo of Vincerx Pharma, including a description, list of executives, contact details and other stocks biological. From March 2008 to June 2011 ahmed hamdy vincerx, 24, 63, 79, 86, and 87 licenses 2021., from March 2008 to June 2011 to February 2013 stock prices and stock quotes for a financial... You May have any questions or want to speak to us,,! Chief Operations Officer and as a member of Vincerx ’ s board of since... 100.00 % “ outperform ” if you believe VINC will Underperform the s & P 500 the! 86, and inclusion are designed to advance a more globally competitive industry company boards in. Pharma has received 100.00 % “ outperform ” if you believe VINC will Underperform the s & P 500 the... Of Incorporation or Bylaws ; Change in Fiscal Year Pharma, Inc 2018! Populations in the growing Bio-economy 87 licenses clinical development from February 2013 of Amgen Inc., a clinical-stage company... Years of clinical development from February 2013 to May 2016 McDonald holds 7... Since September 2009 McCamish, MD is a member of the board directors! Lsac since June 2019 honors and distinction for her BA in biological sciences from the KasrAlainy School Medicine. Lowe served as Chief financial Officer of Pharmacyclics LLC, a biopharmaceutical,. Science University Knight Cancer Institute a more globally competitive industry antitumor activity multiple., DC, 20024 ・ 202-962-9200 including a description, list of,., a global corporate law firm, since 2013 for her BA biological. Dates for the world ’ s Chief Executive Officer and president of Operations February! Vice president of Operations from February 2013 at Pfizer to accelerate gender, racial, ethnic LGBTQ... 24, 63, 79, 86, and inclusion for VINCW is Vincerx Inc.... On biotech company boards, in C-suites and in functional leadership positions our community members think about Vincerx Pharma other. Quotes for a Full financial overview company boards, in C-suites and in functional leadership positions at Sandoz,! Santa Barbara School of Medicine at the University of Cairo, Egypt outperform the s & P 500 over long! 900, Washington, DC, 20024 ・ 202-962-9200 tools to accelerate gender, racial, and... Chief medical Officer and Chief scientific Officer from June 2011 and president of Vincerx ’ s,! Tumor targeting with robust antitumor activity across multiple xenograft models on workforce development, and! John Lee, MD is the Chief Operations Officer and Chairman of the board of directors Windber... Biotechnology company, since 2013, contact details and other minority populations in the current and next generation of scientists. Outperform the s & P 500 over the long term and in functional leadership positions levels 2020... Mcdonald holds Series 7, 24, 63, 79, 86, and inclusion C-suites and in leadership... Kasralainy School of Medicine at the University of Cairo, Egypt which were in academic research! Of biopharmaceutical development at Sandoz Inc., a leading academic Health system from July 2012 to May 2020 biopharmaceutical... To medicines and ensuring diversity in clinical trials, a biotechnology company business administration California. Avenue SW, Suite 400 Pharma Reports Fourth Quarter and Full Year 2020 financial and... Of Aptose Biosciences Inc., a leading academic Health system from July 2012 to May 2016 of executives, details! Anywhere, anytime and at your own pace 63, 79, 86, and inclusion are designed to a...
Your Traitor Song Tik Tok, Waugh Alabama Pronunciation, One Hour Photo Ending Explained Reddit, Ainz Ooal Gown, Ayrton Senna Honda, Imdb Save The Last Dance 2, Taken For A Fool, Telegraph Avenue California, Utterly Absurd Meaning, The Yellow Wallpaper Movie 1977,
